wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47277879-D0FC3070-C775-4614-A107-5B59D7242CFF
Q47277879-D0FC3070-C775-4614-A107-5B59D7242CFF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47277879-D0FC3070-C775-4614-A107-5B59D7242CFF
Dermatologic Reactions to Immune Checkpoint Inhibitors : Skin Toxicities and Immunotherapy.
P2860
Q47277879-D0FC3070-C775-4614-A107-5B59D7242CFF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47277879-D0FC3070-C775-4614-A107-5B59D7242CFF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
911fbe0f77272b353bae5f8154658689c024c74d
P2860
Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH).